Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Consolidated Net Income (2020 - 2025)

Historic Consolidated Net Income for Agilon Health (AGL) over the last 6 years, with Q1 2025 value amounting to $14.0 million.

  • Agilon Health's Consolidated Net Income rose 25084.58% to $14.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 11983.5%. This contributed to the annual value of -$9.8 million for FY2024, which is 8545.67% up from last year.
  • As of Q1 2025, Agilon Health's Consolidated Net Income stood at $14.0 million, which was up 25084.58% from $640000.0 recorded in Q4 2024.
  • Agilon Health's 5-year Consolidated Net Income high stood at $14.0 million for Q1 2025, and its period low was -$63.3 million during Q4 2023.
  • Over the past 5 years, Agilon Health's median Consolidated Net Income value was -$976000.0 (recorded in 2023), while the average stood at -$6.3 million.
  • Data for Agilon Health's Consolidated Net Income shows a peak YoY increase of 130046.62% (in 2023) and a maximum YoY decrease of 390169.49% (in 2023) over the last 5 years.
  • Over the past 5 years, Agilon Health's Consolidated Net Income (Quarter) stood at -$20.9 million in 2021, then rose by 27.96% to -$15.1 million in 2022, then crashed by 320.06% to -$63.3 million in 2023, then surged by 101.01% to $640000.0 in 2024, then surged by 2087.5% to $14.0 million in 2025.
  • Its Consolidated Net Income stands at $14.0 million for Q1 2025, versus $640000.0 for Q4 2024 and -$1.2 million for Q3 2024.